This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zabner, J. et al. Cell 75, 207–216 (1993).
Engelhardt, J. F., Zepeda, M., Cohn, J. A., Yankaskas, J. R. & Wilson, J. M. J. clin. Invest. (in the press).
Engelhardt, J. F. et al. Nature Genet. 2, 240 (1992).
Rosenfeld, M. A. et al. Cell 68, 143–155 (1992).
Rich, D. P. et al. Human Gene Therapy 4, 461 (1993).
Simon, R. H. et al. Human Gene Therapy (in the press).
Hyde, S. C. et al. Nature 362, 250–255 (1993).
Alton, E. W. F. W. et al. Nature Genet. 5, 135 (1993).
Clarke, L. L. et al. Science 257, 1125–1128 (1992).
Wilson, J. M. & Collins, F. S. Nature 359, 195–196 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wilson, J. Vehicles for gene therapy. Nature 365, 691–692 (1993). https://doi.org/10.1038/365691a0
Issue Date:
DOI: https://doi.org/10.1038/365691a0
This article is cited by
-
High-efficiency transfer and expression of AdCMV-p53 in human cervix adenocarcinoma cells induced by subclinical-dose carbon beam radiation
Journal of Cancer Research and Clinical Oncology (2009)
-
Development and Application of a Real-time PCR Method for Pharmacokinetic and Biodistribution Studies of Recombinant Adenovirus
Molecular Biotechnology (2009)
-
Adenovirus-mediated in vivo B7-1 gene transfer induces anti–tumor immunity against pre-established primary tumor and pulmonary metastasis of rat osteosarcoma
Cancer Gene Therapy (2002)
-
Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients
Gene Therapy (2000)
-
Fas ligand—a double-edged sword
Nature Biotechnology (1998)